%20scale(0.100000,-0.100000)'%20fill='%23000000'%20stroke='none'%3e%3cpath%20d='M588%201715%20c-2%20-2%20-23%20-4%20-48%20-6%20-108%20-7%20-216%20-64%20-304%20-162%20l-56%20-61%200%2096%200%2097%20-32%203%20c-18%202%20-52%201%20-75%20-1%20l-43%20-3%200%20-589%20c0%20-554%201%20-589%2018%20-590%2036%20-2%20124%20-1%20127%203%202%201%205%20156%208%20343%205%20360%207%20386%2036%20471%2063%20178%20244%20284%20406%20236%2069%20-20%20119%20-58%20150%20-114%2041%20-75%2043%20-96%2044%20-575%20l1%20-363%2075%200%2075%200%200%2053%20c0%20215%209%20628%2015%20657%2022%20116%2064%20203%20124%20258%2020%2019%2065%2048%20101%2065%2053%2025%2076%2031%20132%2030%20121%200%20220%20-70%20248%20-173%2019%20-69%2021%20-128%2022%20-515%201%20-198%205%20-365%209%20-370%208%20-11%20119%20-12%20136%20-2%205%204%209%20168%208%20404%20-2%20333%20-5%20411%20-19%20478%20-43%20197%20-167%20313%20-349%20323%20-137%208%20-274%20-47%20-355%20-144%20-18%20-21%20-41%20-48%20-51%20-59%20-10%20-11%20-21%20-30%20-25%20-43%20-7%20-22%20-31%20-26%20-31%20-5%200%205%20-11%2032%20-25%2059%20-36%2071%20-109%20138%20-177%20164%20-55%2020%20-139%2040%20-145%2035z'/%3e%3cpath%20d='M63%20202%20c-38%20-2%20-53%20-7%20-57%20-20%20-6%20-19%200%20-61%2010%20-71%203%20-3%20111%20-6%20240%20-6%20256%200%20254%20-1%20254%2058%200%2015%20-6%2030%20-14%2033%20-16%206%20-352%2011%20-433%206z'/%3e%3cpath%20d='M680%20201%20c-30%20-4%20-37%20-14%20-36%20-49%201%20-17%209%20-31%2024%20-38%2025%20-12%20435%20-12%20465%201%2011%205%2017%2018%2017%2040%200%2022%20-6%2035%20-17%2040%20-19%207%20-409%2013%20-453%206z'/%3e%3cpath%20d='M1360%20202%20c-73%20-5%20-78%20-9%20-74%20-48%202%20-20%206%20-39%209%20-43%2010%20-9%20447%20-9%20473%200%2017%207%2022%2016%2022%2044%200%2021%20-6%2038%20-14%2041%20-15%206%20-356%2011%20-416%206z'/%3e%3c/g%3e%3c/svg%3e)
Moderna
MRNA· Manufacturing· Fiscal year ends in December· Structured data only: no proxy read yet
Stéphane Bancel is the CEO of Moderna.
Executives4
See all- 1James MockChief Financial OfficerNot disclosed
- 2Shannon ThymeKlinger Chief Legal Officer and Corporate SecretaryNot disclosed
- 3Stéphane BancelChief Executive OfficerNot disclosed
- 4Stephen Hoge, M.D.PresidentNot disclosed
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Peers12
See allThe FY2025 (Dec) proxy of Moderna names 12 peer companies for pay. Among Moderna and these peers, CEO pay was 3rd highest of 4 and total shareholder return was the lowest of 4.
3rd highest of 4in Moderna and its pay peers, FY2025 (Dec) by CEO pay:
4th highest of 4in Moderna and its pay peers, FY2025 (Dec) by total shareholder return:
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board8
See all- Noubar AfeyanChair · 15 yr on the boardIndependent—Paid as an executive
- Elizabeth NabelDirector · 10 yr on the boardIndependentCompensation and Talent, Product and Technology—Paid as an executive
- François NaderDirector · 6 yr on the boardIndependentCompensation and Talent (Chair), Nominating and Corporate Governance (Chair)—Paid as an executive
- Elizabeth TallettDirector · 5 yr on the boardIndependentAudit (Chair), Compensation and Talent—Paid as an executive
- Abbas HussainDirector · 1 yr on the boardIndependentAudit, Product and Technology—Paid as an executive
- David M. RubensteinDirector · 1 yr on the boardIndependentAudit—Paid as an executive
The board of the latest proxy (FY2025).
Activity
No new filings about this company in the feed.
Filings19
See all| Current report | 8-K | Sep 30, 2026 | — |
| Current report | 8-K | Jul 8, 2026 | — |
| Current report | 8-K | May 11, 2026 | — |
| Proxy statement | DEF 14A | Mar 16, 2026 | FY2025 |
| Annual report | 10-K | Feb 20, 2026 | FY2025 |
| Current report | 8-K | May 5, 2025 | — |
